Primary mediastinal large B-cell lymphoma-refractory

Clinical trials for Primary mediastinal large B-cell lymphoma-refractory explained in plain language.

Never miss a new study

Get alerted when new Primary mediastinal large B-cell lymphoma-refractory trials appear

Sign up with your email to follow new studies for Primary mediastinal large B-cell lymphoma-refractory, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 3 Not yet finished but already full! 1

Could a simple shot replace IV therapy for tough lymphomas?

Disease control Ongoing

This phase 2 trial is testing an injectable form of the immunotherapy drug pembrolizumab (combined with hyaluronidase to help absorption) in 66 adults with classical Hodgkin lymphoma or primary mediastinal large B-cell lymphoma that has returned or not responded to prior treatmen…

Matched conditions: PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA-REFRACTORY

Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control

Last updated Jun 27, 2026 09:03 UTC

Primary mediastinal large B-cell lymphoma-refractory

Get alerted when new Primary mediastinal large B-cell lymphoma-refractory trials appear

Could a simple shot replace IV therapy for tough lymphomas?